ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627777 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627777; 2) Community: the network communities that were significantly associated with the response to NSC 627777; 3) Molecule: the relationships between components within communities and NSC 627777; 4) MDR: the compounds that were significantly associated with the NSC 627777.

NSC Compound Enrichment Correlation
NSC 613012 BENGAMIDE A 0.00838963112864931 0.35090971
NSC 624873 Null 0.00838963112864931 0.1016748
NSC 657271 (+/-) Ethyl cis-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.00838963112864943 0.40586502
NSC 685964 Null 0.00838963112864943 0.22497526
NSC 688228 Null 0.00838963112864943 0.34115319
NSC 694619 Null 0.00838963112864943 0.23022932
NSC 711077 Null 0.00838963112864943 0.59361251
NSC 718781 Erlotinib hydrochloride 0.00838963112864943 -0.28781449
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00838963112864943 0.47979157
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.00838963112864943 0.28021372
Total:107  Current:18    [First] [Prev] [Next] [Last]